APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Angiotensin II Type 1 Receptor (AT1R) Antagonists

Compare research editions
View pricing & licenses

Selected research

Industry Research

Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Research Report 2026

Report ID 173963690526 December 2025120 pages

Choose your research edition.

Industry ResearchAngiotensin II Type 1 Receptor (AT1R) Antagonists Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Angiotensin II Type 1 Receptor (AT1R) Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Angiotensin II Type 1 Receptor (AT1R) Antagonists market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Angiotensin II Type 1 Receptor (AT1R) Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Angiotensin II Type 1 Receptor (AT1R) Antagonists is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Angiotensin II Type 1 Receptor (AT1R) Antagonists is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Angiotensin II Type 1 Receptor (AT1R) Antagonists include Takeda Pharmaceutical Co., Ltd., Shenzhen Salubris Pharmaceuticals Co., Ltd., Sanofi SA, Novartis, Merck, AbbVie, Inc., Cosette Pharmaceuticals, Inc. and Aurobindo Pharma Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Angiotensin II Type 1 Receptor (AT1R) Antagonists Market by Company

Takeda Pharmaceutical Co., Ltd.

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Sanofi SA

Novartis

Merck

AbbVie, Inc.

Cosette Pharmaceuticals, Inc.

Aurobindo Pharma Ltd.

Angiotensin II Type 1 Receptor (AT1R) Antagonists Segment by Type

5mg

10mg

20mg

50mg

80mg

100mg

150mg

400mg

Angiotensin II Type 1 Receptor (AT1R) Antagonists Segment by Application

Hospital

Clinic

Others

Angiotensin II Type 1 Receptor (AT1R) Antagonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Angiotensin II Type 1 Receptor (AT1R) Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiotensin II Type 1 Receptor (AT1R) Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Angiotensin II Type 1 Receptor (AT1R) Antagonists manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Angiotensin II Type 1 Receptor (AT1R) Antagonists by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Angiotensin II Type 1 Receptor (AT1R) Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Manufacturers (2021-2026) Table 8. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue of Manufacturers (2021-2026) Table 9. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Angiotensin II Type 1 Receptor (AT1R) Antagonists, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Angiotensin II Type 1 Receptor (AT1R) Antagonists, Product Type & Application Table 14. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Takeda Pharmaceutical Co., Ltd. Company Information Table 19. Takeda Pharmaceutical Co., Ltd. Business Overview Table 20. Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 22. Takeda Pharmaceutical Co., Ltd. Recent Developments Table 23. Shenzhen Salubris Pharmaceuticals Co., Ltd. Company Information Table 24. Shenzhen Salubris Pharmaceuticals Co., Ltd. Business Overview Table 25. Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 27. Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Developments Table 28. Sanofi SA Company Information Table 29. Sanofi SA Business Overview Table 30. Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 32. Sanofi SA Recent Developments Table 33. Novartis Company Information Table 34. Novartis Business Overview Table 35. Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 37. Novartis Recent Developments Table 38. Merck Company Information Table 39. Merck Business Overview Table 40. Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 42. Merck Recent Developments Table 43. AbbVie, Inc. Company Information Table 44. AbbVie, Inc. Business Overview Table 45. AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 47. AbbVie, Inc. Recent Developments Table 48. Cosette Pharmaceuticals, Inc. Company Information Table 49. Cosette Pharmaceuticals, Inc. Business Overview Table 50. Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 52. Cosette Pharmaceuticals, Inc. Recent Developments Table 53. Aurobindo Pharma Ltd. Company Information Table 54. Aurobindo Pharma Ltd. Business Overview Table 55. Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 57. Aurobindo Pharma Ltd. Recent Developments Table 58. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 59. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region (2021-2026) & (K Units) Table 60. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Region (2021-2026) Table 61. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region (2027-2032) & (K Units) Table 62. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Region (2027-2032) Table 63. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Region (2021-2026) Table 65. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Region (2027-2032) Table 67. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2026) & (K Units) Table 69. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2027-2032) & (K Units) Table 70. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2021-2026) & (US$ Million) Table 71. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2027-2032) & (US$ Million) Table 72. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2026) & (K Units) Table 74. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2027-2032) & (K Units) Table 75. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2021-2026) & (US$ Million) Table 76. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2027-2032) & (US$ Million) Table 77. Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2026) & (K Units) Table 79. Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2027-2032) & (K Units) Table 80. Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2021-2026) & (US$ Million) Table 81. Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2027-2032) & (US$ Million) Table 82. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2026) & (K Units) Table 84. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2027-2032) & (K Units) Table 85. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2021-2026) & (US$ Million) Table 86. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2027-2032) & (US$ Million) Table 87. Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2026) & (K Units) Table 89. Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2027-2032) & (K Units) Table 90. Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2021-2026) & (US$ Million) Table 91. Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2027-2032) & (US$ Million) Table 92. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2026) & (K Units) Table 93. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2027-2032) & (K Units) Table 94. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Type (2021-2026) Table 95. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Type (2027-2032) Table 96. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 97. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 98. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type (2021-2026) Table 99. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type (2027-2032) Table 100. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Type (2021-2026) & (US$/Unit) Table 101. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Type (2027-2032) & (US$/Unit) Table 102. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2026) & (K Units) Table 103. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2027-2032) & (K Units) Table 104. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Application (2021-2026) Table 105. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Application (2027-2032) Table 106. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 107. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 108. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application (2021-2026) Table 109. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application (2027-2032) Table 110. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Application (2021-2026) & (US$/Unit) Table 111. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Application (2027-2032) & (US$/Unit) Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Angiotensin II Type 1 Receptor (AT1R) Antagonists Distributors List Table 115. Angiotensin II Type 1 Receptor (AT1R) Antagonists Customers List Table 116. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Trends Table 117. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Drivers Table 118. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Restraints Table 119. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Image Figure 5. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size (2021-2032) & (US$ Million) Figure 7. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (2021-2032) & (K Units) Figure 8. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price (US$/Unit) & (2021-2032) Figure 9. 5mg Product Image Figure 10. 10mg Product Image Figure 11. 20mg Product Image Figure 12. 50mg Product Image Figure 13. 80mg Product Image Figure 14. 100mg Product Image Figure 15. 150mg Product Image Figure 16. 400mg Product Image Figure 17. Hospital Product Image Figure 18. Clinic Product Image Figure 19. Others Product Image Figure 20. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Manufacturers in 2025 Figure 21. Global Manufacturers of Angiotensin II Type 1 Receptor (AT1R) Antagonists, Manufacturing Sites & Headquarters Figure 22. Global Top 5 and 10 Angiotensin II Type 1 Receptor (AT1R) Antagonists Players Market Share by Revenue in 2025 Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 25. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region in 2025 Figure 26. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region in 2025 Figure 27. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country in 2025 Figure 28. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Country (2021-2032) Figure 29. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Country (2021-2032) Figure 30. United States Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Canada Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Mexico Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country in 2025 Figure 34. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Country (2021-2032) Figure 35. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Country (2021-2032) Figure 36. Germany Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. France Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. U.K. Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Italy Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Russia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Spain Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Netherlands Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Switzerland Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Sweden Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Poland Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country in 2025 Figure 47. Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Country (2021-2032) Figure 48. Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Country (2021-2032) Figure 49. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Japan Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South Korea Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. India Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Australia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Taiwan Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Southeast Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country in 2025 Figure 58. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Country (2021-2032) Figure 59. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Country (2021-2032) Figure 60. Brazil Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Argentina Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Chile Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country in 2025 Figure 64. Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Country (2021-2032) Figure 65. Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Country (2021-2032) Figure 66. Egypt Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. South Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Israel Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Türkiye Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. GCC Countries Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Type (2021-2032) Figure 72. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type (2021-2032) Figure 73. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price (US$/Unit) by Type (2021-2032) Figure 74. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Application (2021-2032) Figure 75. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application (2021-2032) Figure 76. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price (US$/Unit) by Application (2021-2032) Figure 77. Angiotensin II Type 1 Receptor (AT1R) Antagonists Value Chain Figure 78. Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Opportunities and Challenges

Scope & coverage.

Types
  • 5mg
  • 10mg
  • 20mg
  • 50mg
  • 80mg
  • 100mg
  • 150mg
  • 400mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Takeda Pharmaceutical Co., Ltd.
  • Shenzhen Salubris Pharmaceuticals Co., Ltd.
  • Sanofi SA
  • Novartis
  • Merck
  • AbbVie, Inc.
  • Cosette Pharmaceuticals, Inc.
  • Aurobindo Pharma Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size (2021-2032)
  4. 2.2.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (2021-2032)
  5. 2.2.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Average Price (2021-2032)
  6. 2.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 5mg
  9. 2.3.3 10mg
  10. 2.3.4 20mg
  11. 2.3.5 50mg
  12. 2.3.6 80mg
  13. 2.3.7 100mg
  14. 2.3.8 150mg
  15. 2.3.9 400mg
  16. 2.4 Angiotensin II Type 1 Receptor (AT1R) Antagonists by Application
  17. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  18. 2.4.2 Hospital
  19. 2.4.3 Clinic
  20. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Angiotensin II Type 1 Receptor (AT1R) Antagonists, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Angiotensin II Type 1 Receptor (AT1R) Antagonists, Product Type & Application
  8. 3.8 Global Manufacturers of Angiotensin II Type 1 Receptor (AT1R) Antagonists, Established Date
  9. 3.9 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Takeda Pharmaceutical Co., Ltd.
  2. 4.1.1 Takeda Pharmaceutical Co., Ltd. Company Information
  3. 4.1.2 Takeda Pharmaceutical Co., Ltd. Business Overview
  4. 4.1.3 Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  6. 4.1.5 Takeda Pharmaceutical Co., Ltd. Recent Developments
  7. 4.2 Shenzhen Salubris Pharmaceuticals Co., Ltd.
  8. 4.2.1 Shenzhen Salubris Pharmaceuticals Co., Ltd. Company Information
  9. 4.2.2 Shenzhen Salubris Pharmaceuticals Co., Ltd. Business Overview
  10. 4.2.3 Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  12. 4.2.5 Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Developments
  13. 4.3 Sanofi SA
  14. 4.3.1 Sanofi SA Company Information
  15. 4.3.2 Sanofi SA Business Overview
  16. 4.3.3 Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  18. 4.3.5 Sanofi SA Recent Developments
  19. 4.4 Novartis
  20. 4.4.1 Novartis Company Information
  21. 4.4.2 Novartis Business Overview
  22. 4.4.3 Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  24. 4.4.5 Novartis Recent Developments
  25. 4.5 Merck
  26. 4.5.1 Merck Company Information
  27. 4.5.2 Merck Business Overview
  28. 4.5.3 Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  30. 4.5.5 Merck Recent Developments
  31. 4.6 AbbVie, Inc.
  32. 4.6.1 AbbVie, Inc. Company Information
  33. 4.6.2 AbbVie, Inc. Business Overview
  34. 4.6.3 AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  36. 4.6.5 AbbVie, Inc. Recent Developments
  37. 4.7 Cosette Pharmaceuticals, Inc.
  38. 4.7.1 Cosette Pharmaceuticals, Inc. Company Information
  39. 4.7.2 Cosette Pharmaceuticals, Inc. Business Overview
  40. 4.7.3 Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  42. 4.7.5 Cosette Pharmaceuticals, Inc. Recent Developments
  43. 4.8 Aurobindo Pharma Ltd.
  44. 4.8.1 Aurobindo Pharma Ltd. Company Information
  45. 4.8.2 Aurobindo Pharma Ltd. Business Overview
  46. 4.8.3 Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  48. 4.8.5 Aurobindo Pharma Ltd. Recent Developments
5 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Scenario by Region
  1. 5.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region: 2021-2032
  3. 5.2.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region: 2021-2026
  4. 5.2.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region: 2027-2032
  5. 5.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region: 2021-2032
  6. 5.3.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region: 2021-2026
  7. 5.3.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region: 2027-2032
  8. 5.4 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Facts & Figures by Country
  9. 5.4.1 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2032)
  11. 5.4.3 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Facts & Figures by Country
  16. 5.5.1 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2032)
  18. 5.5.3 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Facts & Figures by Country
  41. 5.7.1 South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2032)
  43. 5.7.3 South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2032)
  2. 6.1.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Type (2021-2032)
  4. 6.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2032)
  5. 6.2.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2032)
  2. 7.1.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Application (2021-2032)
  4. 7.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2032)
  5. 7.2.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Value Chain Analysis
  2. 8.1.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Mode & Process
  5. 8.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Distributors
  8. 8.2.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Customers
9 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Analyzing Market Dynamics
  1. 9.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Trends
  2. 9.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Drivers
  3. 9.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Opportunities and Challenges
  4. 9.4 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst